Mangalam Drugs & Organics Limited (BOM:532637)
India · Delayed Price · Currency is INR 30.27
+0.09 (0.30%)
At close: Jun 17, 2026
Mangalam Drugs & Organics Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | -444 | 67.21 | -90.72 | 12.7 | 196.58 |
Depreciation & Amortization | 182.23 | 155.16 | 65.72 | 104.36 | 97.78 |
Other Amortization | - | 10.91 | 9.2 | 5.53 | 4.71 |
Loss (Gain) From Sale of Assets | -0.41 | -0.74 | 0.7 | 0.03 | 1.74 |
Loss (Gain) From Sale of Investments | - | - | - | - | 0.12 |
Other Operating Activities | 100.74 | 120.46 | 193.32 | 138.97 | 112.05 |
Change in Accounts Receivable | -12.24 | -111.28 | 10.47 | -0.43 | 78.22 |
Change in Inventory | 360.28 | -151.62 | 168.88 | -203.61 | -585.18 |
Change in Accounts Payable | -222.59 | 249.86 | -199.04 | 425.26 | 111.52 |
Change in Other Net Operating Assets | 77.77 | 85.99 | -119.41 | -87.58 | 239.55 |
Operating Cash Flow | 41.78 | 425.94 | 39.13 | 395.23 | 257.09 |
Operating Cash Flow Growth | -90.19% | 988.64% | -90.10% | 53.73% | -6.68% |
Capital Expenditures | -118.99 | -202.01 | -118.33 | -279.14 | -276.69 |
Sale of Property, Plant & Equipment | 1.74 | 7.28 | 0.05 | 57.41 | 1.36 |
Investment in Securities | - | - | -0 | - | 2.07 |
Other Investing Activities | 0 | 0 | 0 | 0.01 | 0.01 |
Investing Cash Flow | -117.25 | -194.72 | -118.27 | -221.72 | -273.26 |
Short-Term Debt Issued | 236.03 | - | 169.4 | 24.71 | - |
Long-Term Debt Issued | - | - | - | - | 182.27 |
Total Debt Issued | 236.03 | - | 169.4 | 24.71 | 182.27 |
Short-Term Debt Repaid | - | -26.59 | - | - | -40.85 |
Long-Term Debt Repaid | -17.35 | -41.21 | -44.53 | -63.37 | - |
Total Debt Repaid | -17.35 | -67.8 | -44.53 | -63.37 | -40.85 |
Net Debt Issued (Repaid) | 218.68 | -67.8 | 124.87 | -38.66 | 141.41 |
Other Financing Activities | -162.08 | -149.33 | -72.6 | -127.51 | -111.62 |
Financing Cash Flow | 56.59 | -217.12 | 52.27 | -166.17 | 29.79 |
Miscellaneous Cash Flow Adjustments | - | - | - | 0 | - |
Net Cash Flow | -18.88 | 14.09 | -26.88 | 7.34 | 13.63 |
Free Cash Flow | -77.22 | 223.93 | -79.2 | 116.09 | -19.6 |
Free Cash Flow Margin | -3.33% | 7.05% | -2.16% | 3.14% | -0.43% |
Free Cash Flow Per Share | -4.88 | 14.15 | -5.00 | 7.33 | -1.24 |
Cash Interest Paid | 162.08 | 149.33 | 72.6 | 127.51 | 111.62 |
Cash Income Tax Paid | 2.91 | 0.83 | 0.92 | -0.26 | 88.08 |
Levered Free Cash Flow | 26.75 | 116.22 | -67.72 | -43.82 | -243.32 |
Unlevered Free Cash Flow | 128.05 | 186.1 | -2.67 | 11.93 | -198.3 |
Change in Working Capital | 203.22 | 72.95 | -139.11 | 133.64 | -155.88 |